Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

During the Trading Day
367.48 +1.51 / +0.41%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
363.00 -4.48 / -1.22%
 
Volume: 83.0K

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 579.00, with a high estimate of 676.00 and a low estimate of 400.00. The median estimate represents a +57.56% increase from the last price of 367.48.

Analyst Recommendations

The current consensus among 24 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$3.10
Sales
$1.2B
Reporting Date
May 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.69%
 
 
 
 
 
 
Growthannually 13.58%
 
 
 
 
 
 

Sales

Growthquarterly 10.59%
 
 
 
 
 
 
Growthannually 26.01%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.